Predictors of new-onset kidney disease in a community-based population.
暂无分享,去创建一个
Daniel Levy | Martin G Larson | D. Levy | P. Wilson | C. Fox | M. Larson | B. Culleton | E. Leip | Caroline S Fox | Peter W F Wilson | Bruce Culleton | Eric P Leip | P. Wilson | D. Levy
[1] G. Striker. Modification of diet in renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] R. Foley,et al. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease and cardiac failure. Semin Dial 2003 , 2022 .
[3] T. Greene,et al. Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.
[4] V. D’Agati,et al. Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.
[5] H. Wedel,et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] Teven,et al. EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .
[7] J. Coresh,et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.
[8] D. Levy,et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. , 1999, Archives of internal medicine.
[9] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] Tom Greene,et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.
[11] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[12] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[13] G. Eknoyan,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[15] D. de Zeeuw,et al. Smoking Is Related to Albuminuria and Abnormal Renal Function in Nondiabetic Persons , 2000, Annals of Internal Medicine.
[16] V. Manninen,et al. Effects of hypertension and dyslipidemia on the decline in renal function. , 1995, Hypertension.
[17] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[18] B. Kasiske. Hyperlipidemia in patients with chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] J. Shaw,et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] D. Wesson,et al. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] Deeb N Salem,et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.
[22] J. Coresh,et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). , 2001, Archives of internal medicine.
[23] P. Whelton,et al. Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.
[24] K. Iseki,et al. Influence of smoking and obesity on the development of proteinuria. , 2002, Kidney international.
[25] Colin Baigent,et al. Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.
[26] J. Coresh,et al. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). , 2002, Journal of the American Society of Nephrology : JASN.
[27] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[28] A. Zanchetti,et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.
[29] K. Iseki,et al. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. , 1997, Kidney international.
[30] P. Whelton,et al. A Prospective Study of Blood Pressure and Serum Creatinine: Results From the 'Clue' Study and the ARIC Study , 1993 .
[31] T. Dawber,et al. Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.
[32] W. Kannel,et al. AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY , 1963, Annals of the New York Academy of Sciences.
[33] Tom Greene,et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] T. Greene,et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. , 1995, Annals of internal medicine.
[35] P. Whelton,et al. Risk of End-stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT , 1997 .
[36] W. Kannel,et al. The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.
[37] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] G. Burke,et al. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. , 2000, Kidney international.
[39] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[40] S. Yusuf,et al. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.
[41] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[42] J. Miller,et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. , 1995, Hypertension.
[43] J. Coresh,et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.
[44] G. Beck,et al. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .